Thierry N. Boellaard

The Netherlands Cancer Institute, Oncode Institute

Papers

10

Total Citations

199

H-Index

8

About

Thierry N. Boellaard is a leading researcher in urologic oncology, with a primary focus on improving the preoperative staging and surgical outcomes for prostate cancer. His work centers on integrating advanced imaging—specifically prostate-specific membrane antigen (PSMA) PET and multiparametric MRI—into clinical decision-making. Dr. Boellaard has made seminal contributions by developing and externally validating novel nomograms that incorporate these modern imaging modalities to more accurately predict pelvic lymph-node metastases, with his landmark 2021 multicenter study accumulating over 70 citations. He has also pioneered the use of 3D MRI-based prostate models to guide nerve-sparing robot-assisted radical prostatectomy, and established a standardized method for measuring membranous urethral length to predict post-surgical urinary incontinence. His research extends to predicting early oncological outcomes and exploring AI-driven segmentation for surgical planning. With multiple highly-cited publications in top journals, Dr. Boellaard’s work is directly shaping how clinicians assess risk, plan surgery, and counsel patients, bridging the gap between imaging innovation and personalized surgical care.

Research Focus

Key Achievements

8
H-Index
10
Papers
199
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
External Validation and Addition of Prostate-specific Membrane Antigen Positron Emission Tomography to the Most Frequently Used Nomograms for the Prediction of Pelvic Lymph-node Metastases: an International Multicenter Study
71 citations · 2021
📈 Most Prolific Year: 2021 (4 Papers)
🤝 Key Collaborators: 51
🏛 Institutions: The Netherlands Cancer Institute, Oncode Institute

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago